Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Sheng Wu

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|May 13, 2011
Bim protein degradation contributes to cisplatin resistanceJuan Wang, Jun-Ying Zhou, Gen Sheng Wu
Cancer Research|October 19, 2006
Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapyJing Xu, Jun-Ying Zhou, Gen Sheng Wu
Cancer Research|May 3, 2006
The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell deathJun-Ying Zhou, Yusen Liu, Gen Sheng Wu
Cancer Research|December 20, 2007
ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cellsJuan Wang, Jun-Ying Zhou, Gen Sheng Wu
Cancers|June 22, 2023
The Role of TRAIL in Apoptosis and Immunosurveillance in CancerJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancer Letters|October 12, 2024
Autophagy and cancer therapyJulio M Pimentel, Jun Ying Zhou, Gen Sheng Wu
Molecular Carcinogenesis|October 14, 2022
Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cell Cycle (Georgetown, Tex.)|November 19, 2010
Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERKDong-Jun Peng, Jun-Ying Zhou, Gen Sheng Wu
Cell Cycle (Georgetown, Tex.)|September 17, 2009
Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cellsJuan Wang, Jun-Ying Zhou, Lianfeng Zhang, et al.
Biochemical and Biophysical Research Communications|March 11, 2010
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cellsDong-Jun Peng, Juan Wang, Jun-Ying Zhou, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|May 13, 2011
Bim protein degradation contributes to cisplatin resistanceJuan Wang, Jun-Ying Zhou, Gen Sheng Wu
Cancer Research|October 19, 2006
Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapyJing Xu, Jun-Ying Zhou, Gen Sheng Wu
Cancer Research|May 3, 2006
The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell deathJun-Ying Zhou, Yusen Liu, Gen Sheng Wu
Cancer Research|December 20, 2007
ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cellsJuan Wang, Jun-Ying Zhou, Gen Sheng Wu
Cancers|June 22, 2023
The Role of TRAIL in Apoptosis and Immunosurveillance in CancerJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancer Letters|October 12, 2024
Autophagy and cancer therapyJulio M Pimentel, Jun Ying Zhou, Gen Sheng Wu
Molecular Carcinogenesis|October 14, 2022
Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cell Cycle (Georgetown, Tex.)|November 19, 2010
Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERKDong-Jun Peng, Jun-Ying Zhou, Gen Sheng Wu
Cell Cycle (Georgetown, Tex.)|September 17, 2009
Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cellsJuan Wang, Jun-Ying Zhou, Lianfeng Zhang, et al.
Biochemical and Biophysical Research Communications|March 11, 2010
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cellsDong-Jun Peng, Juan Wang, Jun-Ying Zhou, et al.
Pageof 7